| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2018NatCo...9.4624W |
| P356 | DOI | 10.1038/S41467-018-06853-3 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1038/s41467-018-06853-3 |
| P932 | PMC publication ID | 6218470 |
| P698 | PubMed publication ID | 30397197 |
| P50 | author | Zhe Bao Wu | Q81457526 |
| J Y Huang | Q86922760 | ||
| P2093 | author name string | Yu Wang | |
| Yong Zhang | |||
| Bing Su | |||
| Lei Cao | |||
| Hao Tang | |||
| Lin Cai | |||
| Hong Yao | |||
| Gang Yang | |||
| Yong Xu Wei | |||
| Lichong Yan | |||
| Yan Ting Liu | |||
| Han Bing Shang | |||
| Wei Guo Zhao | |||
| Wei Wei Rui | |||
| Xiao Biao Zhang | |||
| Yu Hang Guo | |||
| Ze Rui Wu | |||
| P2860 | cites work | Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex | Q24295120 |
| Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action | Q24302566 | ||
| A cytoplasmic NF-κB interacting long noncoding RNA blocks IκB phosphorylation and suppresses breast cancer metastasis | Q24322334 | ||
| The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and Igf1r | Q24633774 | ||
| mTOR signaling in growth control and disease | Q24634174 | ||
| Long non-coding RNAs: insights into functions | Q28131764 | ||
| mTOR promotes pituitary tumor development through activation of PTTG1. | Q51571729 | ||
| Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. | Q51856604 | ||
| LncRNA GClnc1 Promotes Gastric Carcinogenesis and May Act as a Modular Scaffold of WDR5 and KAT2A Complexes to Specify the Histone Modification Pattern. | Q52871265 | ||
| Targeting PI3K/mTOR Signaling Displays Potent Antitumor Efficacy against Nonfunctioning Pituitary Adenomas. | Q54168131 | ||
| Tumour-suppressor activity of H19 RNA | Q59071440 | ||
| The STAT3-Binding Long Noncoding RNA lnc-DC Controls Human Dendritic Cell Differentiation | Q61645724 | ||
| Epigenetic lesions at the H19 locus in Wilms' tumour patients | Q72703033 | ||
| Reduced expression of H19 in bone marrow cells from chronic myeloproliferative disorders | Q73230879 | ||
| Structural and functional abnormalities at 11p15 are associated with the malignant phenotype in sporadic adrenocortical tumors: study on a series of 82 tumors | Q73578095 | ||
| Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer | Q80287572 | ||
| Pathogenesis of pituitary tumors | Q83667492 | ||
| Regulation of tumor cell migration and invasion by the H19/let-7 axis is antagonized by metformin-induced DNA methylation. | Q38969133 | ||
| Effects of the estrogen receptor antagonist fulvestrant on F344 rat prolactinoma models | Q39035803 | ||
| Dopamine receptor D2S gene transfer improves the sensitivity of GH3 rat pituitary adenoma cells to bromocriptine | Q39067641 | ||
| LncRNA-mediated regulation of cell signaling in cancer. | Q39366670 | ||
| mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs | Q39699300 | ||
| 4E-binding protein 1, a cell signaling hallmark in breast cancer that correlates with pathologic grade and prognosis | Q40187965 | ||
| Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells | Q40546587 | ||
| Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis | Q40919536 | ||
| FKBPs and the Akt/mTOR pathway | Q41779228 | ||
| ULK1 inhibits mTORC1 signaling, promotes multisite Raptor phosphorylation and hinders substrate binding | Q41953170 | ||
| H19 derived microRNA-675 regulates cell proliferation and migration through CDK6 in glioma | Q42239876 | ||
| The H19/let-7 double-negative feedback loop contributes to glucose metabolism in muscle cells. | Q42686318 | ||
| Examination of IGF2 and H19 loss of imprinting in bladder cancer. | Q44048722 | ||
| Determination of subcutaneous tumor size in athymic (nude) mice | Q46296687 | ||
| Activation of DRD5 (dopamine receptor D5) inhibits tumor growth by autophagic cell death | Q46350232 | ||
| Bromocriptine treatment of invasive giant prolactinomas involving the cavernous sinus: results of a long-term follow up. | Q46969695 | ||
| TOS motif-mediated raptor binding regulates 4E-BP1 multisite phosphorylation and function | Q28204144 | ||
| 4E-binding protein 1: a key molecular "funnel factor" in human cancer with clinical implications | Q28240822 | ||
| Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks | Q28255399 | ||
| SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity | Q28262782 | ||
| Polymorphisms in the H19 gene and the risk of bladder cancer | Q28268067 | ||
| mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events | Q28281590 | ||
| Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G | Q28285121 | ||
| PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding | Q28302887 | ||
| The H19 locus acts in vivo as a tumor suppressor | Q28508794 | ||
| mTORC1 and muscle regeneration are regulated by the LINC00961-encoded SPAR polypeptide | Q28588606 | ||
| A chromatin landmark and transcription initiation at most promoters in human cells | Q29547180 | ||
| Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40 | Q29617097 | ||
| Overexpression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancer | Q33688617 | ||
| The splicing factor SF2/ASF regulates translation initiation by enhancing phosphorylation of 4E-BP1. | Q34774397 | ||
| The antisense transcriptomes of human cells | Q34895481 | ||
| Translational control and metastatic progression: enhanced activity of the mRNA cap-binding protein eIF-4E selectively enhances translation of metastasis-related mRNAs | Q35125475 | ||
| Dopamine agonists and pituitary tumor shrinkage | Q35259108 | ||
| Modeling familial cancer with induced pluripotent stem cells | Q35428604 | ||
| mTOR kinase inhibition causes feedback-dependent biphasic regulation of AKT signaling | Q35581650 | ||
| 4E-BP1 is a key effector of the oncogenic activation of the AKT and ERK signaling pathways that integrates their function in tumors | Q35778060 | ||
| Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma | Q36243433 | ||
| H19 lncRNA alters DNA methylation genome wide by regulating S-adenosylhomocysteine hydrolase | Q36438183 | ||
| Advances in the treatment of prolactinomas | Q36480692 | ||
| Suppression of mTOR pathway and induction of autophagy-dependent cell death by cabergoline | Q36629594 | ||
| Unique expression patterns of H19 in human testicular cancers of different etiology. | Q36843920 | ||
| Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation | Q36971030 | ||
| Combination inhibition of PI3K and mTORC1 yields durable remissions in mice bearing orthotopic patient-derived xenografts of HER2-positive breast cancer brain metastases | Q37079718 | ||
| The pathogenesis of pituitary tumors | Q37463057 | ||
| Cross-Linking Immunoprecipitation and qPCR (CLIP-qPCR) Analysis to Map Interactions Between Long Noncoding RNAs and RNA-Binding Proteins | Q37478468 | ||
| Signal integration by JNK and p38 MAPK pathways in cancer development | Q37560607 | ||
| AKT-mediated stabilization of histone methyltransferase WHSC1 promotes prostate cancer metastasis | Q37730639 | ||
| The H19 locus: role of an imprinted non-coding RNA in growth and development. | Q37756737 | ||
| The PI3K/AKT/mTOR pathway in the pathophysiology and treatment of pituitary adenomas | Q38232872 | ||
| mTOR Signaling in Growth, Metabolism, and Disease. | Q38747508 | ||
| GSK3-mediated raptor phosphorylation supports amino-acid-dependent mTORC1-directed signalling | Q38837034 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | general chemistry | Q909510 |
| P304 | page(s) | 4624 | |
| P577 | publication date | 2018-11-05 | |
| P1433 | published in | Nature Communications | Q573880 |
| P1476 | title | Inhibition of mTORC1 by lncRNA H19 via disrupting 4E-BP1/Raptor interaction in pituitary tumours | |
| P478 | volume | 9 |
| Q90462207 | Genome-Wide Analysis and Function Prediction of Long Noncoding RNAs in Sheep Pituitary Gland Associated with Sexual Maturation |
| Q91829521 | Identification of Transcriptional Metabolic Dysregulation in Subtypes of Pituitary Adenoma by Integrated Bioinformatics Analysis |
| Q92125695 | LINC00511 contributes to glioblastoma tumorigenesis and epithelial-mesenchymal transition via LINC00511/miR-524-5p/YB1/ZEB1 positive feedback loop |
| Q91713405 | Long Non-coding RNAs: Major Regulators of Cell Stress in Cancer |
| Q92537519 | Multiomics-Based Signaling Pathway Network Alterations in Human Non-functional Pituitary Adenomas |
| Q90580125 | Novel insights into Pituitary Tumorigenesis: Genetic and Epigenetic Mechanisms |
| Q91070697 | The Role of Long Noncoding RNAs in the Biology of Pituitary Adenomas |
Search more.